Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Imaging Diagnostic Systems' laser mammogram approved in Australia

This article was originally published in Clinica

Executive Summary

The Australian Therapeutic Goods Administration has approved Imaging Diagnostic Systems' (IDS) CT laser mammography (CTLM) system. It will be distributed in Australia by Jainsons. The CTLM is a noninvasive breast imaging system that uses continuous wave laser technology and patented algorithms to produce 3D images of the breast. It can provide information about blood distribution and new blood vessel formation that is often associated with cancer, and is designed to be used in conjunction with conventional mammography. The device is CE marked for sale in Europe and is approved in Canada. It is not yet available in the US, where IDS (Fort Lauderdale, Florida) is currently carrying out the clinical studies required for a premarket approval (PMA) application.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT045391

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel